Provided by Tiger Fintech (Singapore) Pte. Ltd.

Moderna, Inc.

23.51
-1.8800-7.40%
Pre-market: 23.820.3100+1.32%07:43 EDT
Volume:31.29M
Turnover:743.65M
Market Cap:9.15B
PE:-3.12
High:25.42
Open:25.23
Low:23.18
Close:25.39
52wk High:75.37
52wk Low:23.15
Shares:389.08M
Float Shares:363.29M
Volume Ratio:2.80
T/O Rate:8.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.5273
EPS(LYR):-9.2734
ROE:-27.50%
ROA:-14.78%
PB:0.97
PE(LYR):-2.54

Loading ...

Amid Vaccine Controversy, Pfizer Says New Covid Shots Are Effective -- Barrons.com

Dow Jones
·
Sep 09

FACTBOX-US Health Secretary Kennedy's vaccine actions and policy positions

Reuters
·
Sep 05

U.S. Health Secretary Kennedy on Covid Vaccines: Anybody Can GET the Booster

THOMSON REUTERS
·
Sep 04

U.S. Health Secretary Kennedy on Covid Vaccines: Access Depends on the States

THOMSON REUTERS
·
Sep 04

U.S. Health Secretary Kennedy on Covid Vaccines: Medicare and Medicaid Will Still Pay for Them

THOMSON REUTERS
·
Sep 04

U.S. Health Secretary Kennedy on Covid: Nobody Knows How Many Americans Died, Cited Data Chaos

THOMSON REUTERS
·
Sep 04

Republican U.S. Senator Cassidy on Covid Vaccine Recommendations: We're Effectively Denying People the Vaccine

THOMSON REUTERS
·
Sep 04

Market Chatter: Florida Surgeon General Working to End Vaccine Mandates

MT Newswires Live
·
Sep 04

Moderna Recognizes the Success of Operation Warp Speed and Its Ongoing Commitment to Transparency

THOMSON REUTERS
·
Sep 04

Moderna: Committed to Transparency and Welcomes the Opportunity to Highlight the Extensive Research Regarding Our Covid-19 Vaccine

THOMSON REUTERS
·
Sep 04

Moderna Inc. Publishes Study on Clinical Burden of Propionic Acidemia in Japan

Reuters
·
Sep 04

Moderna Inc. Publishes Interim Data on mRNA-3705 Therapy for Methylmalonic Acidemia

Reuters
·
Sep 04

Moderna Unveils Promising Data on mRNA Therapies for Inborn Metabolic Disorders at 2025 ICIEM Congress

Reuters
·
Sep 02

Moderna Inc. Stock Falls 2.5%, Underperforms Competitors

Dow Jones
·
Aug 29

FACTBOX-Which COVID-19 vaccines are FDA approved in US?

Reuters
·
Aug 28

BRIEF-Moderna Gets FDA Approval For Updated COVID-19 Vaccines Targeting LP.8.1 Variant Of SARS-COV-2

Reuters
·
Aug 28

US FDA narrows under-65 COVID vaccine eligibility; maintains full access for older Americans

Reuters
·
Aug 28

Moderna: Updated Formula for Spikevax Is NOW Approved for Individuals 6 Months Through 64 Years of Age

THOMSON REUTERS
·
Aug 28

Moderna Receives U.S. FDA Approval for Updated Covid-19 Vaccines Targeting Lp.8.1 Variant of Sars-Cov-2

THOMSON REUTERS
·
Aug 28

New Covid-19 Boosters Are Coming Soon. Not Everyone Will Be Eligible to Get One. -- WSJ

Dow Jones
·
Aug 28